Anxiety News and Research

Latest Anxiety News and Research

Ingredients for an "anti-aging potion"

Aging without getting old? It's largely possible, according to the June issue of Mayo Clinic Health Letter.

24 Jun 2010

Helping sick or disabled loved ones may promote well being of helpers, study finds

Although long-term care of sick or disabled loved ones is widely recognized as a threat to the caregiver's health and quality of life, a new study led by University at Buffalo psychologist Michael Poulin, PhD, finds that in some contexts, helping valued loved ones may promote the well being of helpers.

23 Jun 2010

Ultrasound-guided diffuse optical tomography holds promise for ascertaining early-stage invasive breast cancer

By combining two relatively inexpensive technologies based on sound and light waves, researchers hope to lower the rate at which women undergo breast biopsies for suspicious lesions. Results of the study on ultrasound-guided optical tomography are published in the online edition and the August print issue of Radiology.

22 Jun 2010

Omega-3 effective for treating depression in patients without anxiety disorders

The use of Omega-3 supplements is effective among patients with major depression who do not have anxiety disorders, according to a study directed by Dr. Fran-ois Lesp-rance of the Centre de recherche du Centre hospitalier at the Universit- de Montr-al (CRCHUM), head of CHUM's Department of Psychiatry and a professor at the Universit- de Montr-al. The study was published June 15 in the online Journal of Clinical Psychiatry.

22 Jun 2010

"Lap Band" weight loss surgery improves physical, psychological health in extremely obese adults

One year after weight loss surgery with laparoscopic gastric banding, extremely obese adults demonstrate not only better physical health but also improved psychological health, a new study shows. The results will be presented Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.

21 Jun 2010

Achieving remission in patients lessens burden of RA on societies with aging populations: Study

Achieving disease remission in patients with rheumatoid arthritis provides superior outcomes across measures of socio-economic importance including work productivity and quality of life according to results presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. These Austrian findings are reported in addition to improvements in measures of physical functioning, when compared with RA patients achieving low disease activity.

21 Jun 2010

Research findings support the need to establish standards for DFSA care

New toxicology findings reveal the presence of drugs and/or alcohol in 76 per cent of women and men who suspect they were victims of drug-facilitated sexual assault. Of those, 64 per cent did not report voluntarily consuming the drugs found, supporting their belief that they may have been slipped a drug. In addition, unexpected male DNA was found in a substantial number of cases, confirming sexual activity.

19 Jun 2010

esperanza Magazine's feature article Marriage Matters wins 2010 MHA Media Award

esperanza Magazine's feature article "Marriage Matters" has won a Mental Health America 2010 Media Award in the national magazine category. esperanza Magazine was among 15 media outlets honored by MHA at an awards luncheon held June 12 during the advocacy organization's 2010 annual conference in Washington, DC. The awards honor excellence in reporting and portrayals of mental health issues.

19 Jun 2010

Yoga and meditation in Western medicine

Meditation and deep breathing techniques, as a form of relaxation, have been in use for thousands of years. However, in the unique new book Pranayama (published by AuthorHouse), author Dr. Ravinder Jerath presents explanations and illustrations to more easily and succinctly explain exactly how meditation and deep breathing techniques beneficially affect the human body.

18 Jun 2010

USFDA approves Sun Pharma's generic Xanax ANDA

Sun Pharma announced that USFDA has granted an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Xanax®, alprazolam tablets.

18 Jun 2010

Research examines relationship between body-image distortion and weight-loss behaviors

Normal weight and underweight teenage girls who falsely believe they are overweight are at significantly greater risk of succumbing to unnecessary and unsafe weight-loss behaviors than girls who can accurately assess their weight status, according to new research by a University of Illinois expert in eating disorders and body-image perception.

18 Jun 2010

Study finds anxiety/panic disorder as most-disabling psychiatric disorder associated with TS

An assessment of patients with adult Tourette syndrome (TS) to identify clinical factors that contribute to psychosocial and occupational disabilities resulting from the vocal or motor tics that define TS found that anxiety/panic disorder may be the most disabling psychiatric condition associated with the disorder.

18 Jun 2010

States want Congress to keep extra Medicaid money flowing

Illinois will face a $750 million shortfall in the fiscal year beginning in July if Congress doesn't extend increased Medicaid funding, originally part of last year's economic stimulus, Illinois Statehouse News reports. "The increased Medicaid reimbursements stand as a national issue as the recession lingers. Thirty states have crafted budgets for the fiscal year set to begin July 1 based on an extension of the increased payments, according to the National Conference of State Legislatures" (Massingale, 6/16).

18 Jun 2010

Study reveals increase of enzyme MAO-A in female brain during immediate postpartum period

Within the first week after giving birth, up to 70 percent of all women experience symptoms of the baby blues. While most women recover quickly, up to 13 percent of all new mothers suffer from symptoms of a clinical-level postpartum depression. Postpartum depression is defined as a major depressive episode starting within 4 weeks after delivery and is a significant public health problem. Postpartum blues represents a major risk factor for developing postpartum depression and severe postpartum blues symptoms can be viewed as a prodromal stage for postpartum depression.

17 Jun 2010

Positive results from Phase I clinical trial of GLYX-13 presented at NCDEU meeting

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that it presented data at the NCDEU 50th Anniversary Meeting showing that its novel mechanism compound GLYX-13 appeared safe in a Phase I trial. GLYX-13 is a glycine site functional partial agonist selective modulator of the NMDA receptor that is being developed initially for use in depression as adjunctive therapy.

17 Jun 2010

Neurocrine Biosciences, Boehringer Ingelheim collaborate to develop GPR119 agonists for Type II diabetes

Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.

17 Jun 2010

Scientists identify symptoms associated with late-onset hypogonadism

Scientists have for the first time identified the symptoms associated with what has been termed late-onset hypogonadism or 'male menopause' caused by a reduction in testosterone production in ageing men.

17 Jun 2010

CAMFT listed in 2010 Associations Advance America Honor Roll

The California Association of Marriage and Family Therapists has been named to the 2010 Associations Advance America Honor Roll, a national awards competition sponsored by the American Society of Association Executives & The Center for Association Leadership, Washington, D.C.

16 Jun 2010

Stress-related psychiatric disorders more common among women: Study

There may be a biological reason why depression and other stress-related psychiatric disorders are more common among women compared to men. Studying stress signaling systems in animal brains, neuroscience researchers found that females are more sensitive to low levels of an important stress hormone and less able to adapt to high levels than males.

16 Jun 2010

Abbott, Neurocrine enter collaboration to develop, commercialize elagolix for endometriosis-related pain

Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.

16 Jun 2010

Anxiety News and Research

Latest Anxiety News and Research

Ingredients for an "anti-aging potion"

Helping sick or disabled loved ones may promote well being of helpers, study finds

Ultrasound-guided diffuse optical tomography holds promise for ascertaining early-stage invasive breast cancer

Omega-3 effective for treating depression in patients without anxiety disorders

"Lap Band" weight loss surgery improves physical, psychological health in extremely obese adults

Achieving remission in patients lessens burden of RA on societies with aging populations: Study

Research findings support the need to establish standards for DFSA care

esperanza Magazine's feature article Marriage Matters wins 2010 MHA Media Award

Yoga and meditation in Western medicine

USFDA approves Sun Pharma's generic Xanax ANDA

Research examines relationship between body-image distortion and weight-loss behaviors

Study finds anxiety/panic disorder as most-disabling psychiatric disorder associated with TS

States want Congress to keep extra Medicaid money flowing

Study reveals increase of enzyme MAO-A in female brain during immediate postpartum period

Positive results from Phase I clinical trial of GLYX-13 presented at NCDEU meeting

Neurocrine Biosciences, Boehringer Ingelheim collaborate to develop GPR119 agonists for Type II diabetes

Scientists identify symptoms associated with late-onset hypogonadism

CAMFT listed in 2010 Associations Advance America Honor Roll

Stress-related psychiatric disorders more common among women: Study

Abbott, Neurocrine enter collaboration to develop, commercialize elagolix for endometriosis-related pain

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Anxiety News and Research

Latest Anxiety News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in